1. In vivo administration of purified human interleukin-2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL-2;Lotze;J. Immunol,1985
2. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2;Rosenstein;J. Immunol,1986
3. Activation of the complement system during immunotherapy with recombinant IL-2: Relation to the development of side effects;Thijs;J. Immunol,1990
4. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury;Aronson;J. Immunol,1988
5. Interleukin-2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis;Damle;J. Immunol,1987